1. Home
  2. PPBT vs VSTD Comparison

PPBT vs VSTD Comparison

Compare PPBT & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$0.71

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

VSTD

Vestand Inc.

N/A

Current Price

$0.23

Market Cap

6.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
PPBT
VSTD
Founded
2010
2016
Country
Israel
United States
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PPBT
VSTD
Price
$0.71
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
742.9K
635.1K
Earning Date
11-14-2025
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,902,861.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.39
52 Week Low
$0.53
$0.20
52 Week High
$5.20
$5.63

Technical Indicators

Market Signals
Indicator
PPBT
VSTD
Relative Strength Index (RSI) 41.65 N/A
Support Level $0.69 N/A
Resistance Level $0.87 N/A
Average True Range (ATR) 0.05 0.00
MACD -0.01 0.00
Stochastic Oscillator 17.03 0.00

Price Performance

Historical Comparison
PPBT
VSTD

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About VSTD Vestand Inc.

Vestand Inc is a California-based fast-growing restaurant operator expanding into the real estate investment and development sector. It is a PropTech company engaged in AI-driven real estate investment and security token offerings (STOs). It provides services such as Property Acquisition, Property Development, Financial Management, and Property Management.

Share on Social Networks: